Year: 2019

Entra, OBOS and Camar has reached an agreement with Stavanger Utvikling regarding development of the area Jåttåvågen Fase 2 (“JF 2”). JF 2 is land plot adjacent to Hinna Park with an estimated development potential of minimum 205,000 sqm, split on 60 % residential and 40 % office. The zoning and development of the area has a long-term horizon and is expected to be realized over the next 25 years. Entra’s share of the partnership is 12.5 %. The up-front payment for Entra’s share of the equity is NOK 12.5 million.For further queries please contact: Sonja Horn, CEO, tel: +47 90 56 84 56, email: sh@entra.no 

DENVER, Dec. 09, 2019 (GLOBE NEWSWIRE) — solo sciences, an Akerna company (Nasdaq: KERN), the world’s first cryptographically-secured product authentication system, has entered into an agreement with leading cannabis design and technology firm, 14thRound to add its solo*CODE authentication tag to its vaporizer brands. The deal further advances solo’s efforts to address regulatory compliance throughout the entire supply chain, enhancing product safety for consumers.Thanks to this collaboration, solo sciences trust mark authentication will be a default feature for 14th Round’s high-profile cannabis vaporizer brands. 14th Round creates and supplies custom hardware and packaging for an estimated 40 plus percent of California’s vaporizer market, the largest in the world. 14th Round is also the number one vaporizer and packaging supplier...

Reitir hafa undirritað sérleyfissamning (e. Franchise Agreement) við Hyatt Hotels Corporation um rekstur hótels í fasteign félagsins að Laugavegi 176 í Reykjavík. Hótelið mun verða um 169 herbergja hótel með allri tilheyrandi starfsemi, svo sem veitingastað, bar, fundaaðstöðu og heilsurækt. Mun hótelið verða fyrsta hótelið sem rekið verður undir merkjum Hyatt á Norðurlöndunum. Vörumerkið leggur áherslu á hátt þjónustustig, vandað efnisval, fallega hönnun og nútímaleg herbergi í háum gæðaflokki.Framkvæmdir við umbreytingu fasteignarinnar í hótel munu hefjast á síðari hluta næsta árs og er áætlað að hótelið hefji starfsemi sína á síðari hluta ársins 2022. Reitir stefna að því að halda eigninni í eignasafni félagsins til lengri tíma litið, en selja rekstrarfélagið til traustra rekstraraðila.Fjárfesting Reita í endurbyggingu fasteignarinnar...

CALGARY, Alberta, Dec. 09, 2019 (GLOBE NEWSWIRE) — Pan Orient Energy Corp. (“Pan Orient”) (POE – TSXV) provides an operations update.INDONESIAEast Jabung Production Sharing Contract (Pan Orient 49% & Non Operator)Drilling of the Anggun-1X exploration well commenced on November 14, 2019 and has reached a total depth of 1,232.7 meters within basement, after penetrating the main Gumai sandstone and Batu Raja limestone reservoir targets.  Despite oil shows and some oil staining within a number of Gumai formation sandstones, wireline sampling indicated minor amounts of oil and gas with predominantly water. The Batu Raja formation target interval proved to be a tight, low permeability limestone with no reservoir potential.Follow-up activities will include the immediate plugging and abandonment of the well and withdrawal from the...

Not for distribution to U.S. news wire services or for dissemination in the United StatesTORONTO, Dec. 09, 2019 (GLOBE NEWSWIRE) — Avante Logixx Inc. (TSX.V: XX) (OTC: ALXXF) (“Avante” or the “Company”) announces that Mr. Drew Coles, Independent Chair of the Board of Directors, has accepted a new position with a global advisory firm and due to potential conflicts of interest is resigning from the Board of Directors effective December 31, 2019. Mr. Sam Duboc will be appointed Chair of the Board until the next Annual General Meeting. In the interim, the Company will be searching for additional Board Members to fill the vacancies.“Avante has a great future ahead and is executing well on its strategy.  The organization and leadership are traveling on a great path toward success.  It has been a privilege to be part of this organization...

This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail.Aino Health AB (publ) (“Aino” or “the Company”) today announces the outcome of the exercise of warrants of series TO1 and TO2, issued in conjunction with the Company’s rights issue of units in August 2018. The exercise period for both series ended on 29 November 2019 and in total 1 344 warrants of series TO1 were exercised for the subscription of 672 shares at a subscription price of SEK 5,95 per share. No warrants of series TO2 were exercised for subscription shares. Thus, Aino will receive approximately SEK 4 000 before issuance costs.Exercised warrants have been replaced with interim shares pending registration by the Swedish Companies Registration Office (Sw. Bolagsverket). Conversion of interim shares...

Aino Health AB (publ) (“Aino” eller “Bolaget”) meddelar idag utfallet från nyttjandeperioden av teckningsoptioner av serie TO1 och serie TO2 som emitterades i samband med Ainos företrädesemission respektive riktade emission av units i augusti 2018. Nyttjandeperioden för båda serierna avslutades den 29 november 2019 och totalt nyttjades 1 344 teckningsoptioner av serie TO1 för teckning av 672 aktier till teckningskurs 5,95 SEK per aktie. Inga teckningsoptioner av serie TO2 utnyttjades för teckning av aktier. Genom teckningsoptionerna av serie TO1 tillförs Aino därmed cirka 4 000 SEK före emissionskostnader.Nyttjade teckningsoptioner har ersatts med interimsaktier (IA) i väntan på registrering hos Bolagsverket. Omvandling av interimsaktier till stamaktier beräknas ske omkring den 20 december 2019.Antal aktier och...

FOUNTAIN INN, S.C., Dec. 09, 2019 (GLOBE NEWSWIRE) — AVX Corporation, a leading manufacturer and supplier of advanced electronic components and interconnect, sensor, control, and antenna solutions, has announced its continued support of the GEOX DRAGON Formula-E racing team for the new 2019–2020 ABB FIA Formula-E Championship racing season, which kicked off in Diriyah, Saudi Arabia, on Friday, November 22. For the second-straight year, AVX is partnering with Mouser Electronics, TTI, Inc., and Molex to sponsor the world’s premier racing series with all-electric vehicles. Comprised of 14 races that take place in 12 incredible cities across five continents, the ABB FIA Formula-E Championship is firmly rooted in three core values — energy, environment, and entertainment — and is designed to help drive the change towards an all-electric...

MALVERN, Pa., Dec. 09, 2019 (GLOBE NEWSWIRE) — Ocugen, Inc., (NASDAQ: OCGN), ), a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases, today announced that it has completed 50% of enrollment of its Phase 3 clinical trial for OCU300 for patients with ocular Graft Versus Host Disease (oGVHD).  Ocugen is the first and only company to receive Orphan Drug Designation for a product candidate designed to treat oGVHD and is the first company to conduct a Phase 3 clinical trial in patients with this disease.The ongoing Phase 3 trial is a double-masked, placebo-controlled 84-day trial, in which 60 patients will be randomized in a 2:1 ratio to receive either OCU300 (brimonidine 0.18% nanoemulsion) or a placebo.  The...

MIAMI, FL, Dec. 09, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce its new expanded shareholder communications initiative in order to improve corporate transparency and visibility, benefitting both shareholders and Company management. The Company will be creating and administering a “Telegram Group” on the popular social media platform, Telegram, as well as adding leading global push notifications service, Get Push Monkey, to its corporate website at ProgressiveCareUS.com.Management notes that this expanded shareholder communications initiative has been put into place in response to an increase in shareholder and public requests for information following the release of the...